Mitochondrial Genome Analysis of Primary Open Angle Glaucoma Patients

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Banerjee, Deblina ^a,e   Banerjee, Antara ^a,f   Mookherjee, Suddhasil ^a,g   Vishal, Mansi ^a,b   Mukhopadhyay, Arijit ^b   Sen, Abhijit ^c   Basu, Analabha ^d   Ray, Kunal ^a,h  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^c Dristi Pradip   (India)

^d NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^e NATIONAL CANCER INSTITUTE   (United States)

^f BANGABASI COLLEGE   (India)

^g NATIONAL EYE INSTITUTE   (United States)

^h ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; MYOCILIN; OPTINEURIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE FREQUENCY; GENE MUTATION; GENE SEGREGATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MITOCHONDRIAL GENOME; MOLECULAR PATHOLOGY; MUTATION RATE; MYOC GENE; ND5 GENE; NUCLEOTIDE SEQUENCE; OPEN ANGLE GLAUCOMA; OPTN GENE; OXIDATIVE STRESS; WDR36 GENE;

EID: 84881096961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070760     Document Type: Article

References (96)

1. Pascolini D, Mariotti SP, (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96: 614-8.
2. Ray K, Mukhopadhyay A, Acharya M (2003) Recent advances in molecular genetics of glauocma. Mol Cell Biochem.
3. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, et al. (1997) Identification of a gene that causes primary open angle glaucoma. Science 275: 668-70.
4. Rezaie T, Child A, Hitchings R, Brice G, Miller L, et al. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-9.
5. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, et al. (2005) Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 14: 725-33.
6. Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstatter JH, et al. (2009) Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet 85: 447-56.
7. Pasutto F, Keller KE, Weisschuh N, Sticht H, Samples JR, et al. (2012) Variants in ASB10 are associated with open-angle glaucoma. Hum Mol Genet 21: 1336-49.
8. Loewen N, Fautsch MP, Peretz M, Bahler CK, Cameron JD, et al. (2001) Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther 12: 2109-19.
9. Seiler T, Wollensak J, (1985) The resistance of the trabecular meshwork to aqueous humor outflow. Graefes Arch Clin Exp Ophthalmol 223: 88-91.
10. Leske MC, (2007) Open-angle glaucoma - an epidemiologic overview. Ophthalmic Epidemiol 14: 166-72.
11. Lee S, Van Bergen NJ, Kong GY, Chrysostomou V, Waugh HS, et al. (2011) Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies. Exp Eye Res 93: 204-12.
12. Katano H, Fujita K, Kato T, Asai K, Kawamura Y, et al. (2001) A metabotropic glutamate receptor antagonist, alpha-methyl-4-carboxyphenylglycine, attenuates immediate early gene mRNA expression following traumatic injury in cultured rat cortical glial cells. Neurosci Lett 306: 101-5.
13. Joseph JA, Denisova NA, Bielinski D, Fisher DR, Shukitt-Hale B, (2000) Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech Ageing Dev 116: 141-53.
14. Olanow CW, (1992) An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 32Suppl: S2-9.
15. Chrysostomou V, Rezania F, Trounce IA, Crowston JG, (2013) Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 13: 12-5.
16. Lascaratos G, Garway-Heath DF, Willoughby CE, Chau KY, Schapira AH, (2012) Mitochondrial dysfunction in glaucoma: understanding genetic influences. Mitochondrion 12: 202-12.
17. Sacca SC, Izzotti A, Rossi P, Traverso C, (2007) Glaucomatous outflow pathway and oxidative stress. Exp Eye Res 84: 389-99.
18. Cooper JM, Mann VM, Schapira AH, (1992) Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci 113: 91-8.
19. Ojaimi J, Masters CL, Opeskin K, McKelvie P, Byrne E, (1999) Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev 111: 39-47.
20. Boveris A, Navarro A, (2008) Brain mitochondrial dysfunction in aging. IUBMB Life 60: 308-14.
21. Navarro A, Boveris A, (2007) The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292: C670-86.
22. Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, et al. (2012) A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta 1820: 553-64.
23. Reddy PH, Reddy TP, (2011) Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res 8: 393-409.
24. Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, et al. (2012) Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One 7: e32737.
25. Exner N, Lutz AK, Haass C, Winklhofer KF, (2012) Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J 31: 3038-62.
26. Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R, Lipton SA, (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 15: 706-16.
27. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E, (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9: 505-18.
28. Calandrella N, Scarsella G, Pescosolido N, Risuleo G, (2007) Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension. Mol Cell Biochem 301: 155-63.
29. Munemasa Y, Kitaoka Y, Kuribayashi J, Ueno S, (2010) Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J Neurochem 115: 1508-19.
30. Ju WK, Liu Q, Kim KY, Crowston JG, Lindsey JD, et al. (2007) Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest Ophthalmol Vis Sci 48: 2145-51.
31. Ju WK, Kim KY, Lindsey JD, Angert M, Patel A, et al. (2009) Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells. Mol Vis 15: 120-34.
32. Abu-Amero KK, Morales J, Bosley TM, (2006) Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 47: 2533-41.
33. He Y, Leung KW, Zhang YH, Duan S, Zhong XF, et al. (2008) Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants. Invest Ophthalmol Vis Sci 49: 1447-58.
34. Izzotti A, Sacca SC, Longobardi M, Cartiglia C, (2010) Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol 128: 724-30.
35. Mabuchi F, Tang S, Kashiwagi K, Yamagata Z, Iijima H, et al. (2007) The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol 143: 125-130.
36. Wolf C, Gramer E, Muller-Myhsok B, Pasutto F, Reinthal E, et al. (2009) Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study. BMC Med Genet 10: 91.
37. Banerjee D, Bhattacharjee A, Ponda A, Sen A, Ray K, (2012) Comprehensive analysis of myocilin variants in east Indian POAG patients. Mol Vis 18: 1548-57.
38. Mukhopadhyay A, Komatireddy S, Acharya M, Bhattacharjee A, Mandal AK, et al. (2005) Evaluation of Optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol Vis 11: 792-7.
39. Mookherjee S, Chakraborty S, Vishal M, Banerjee D, Sen A, et al. (2011) WDR36 variants in East Indian primary open-angle glaucoma patients. Mol Vis 17: 2618-27.
40. Acharya M, Mookherjee S, Bhattacharjee A, Bandyopadhyay AK, Daulat Thakur SK, et al. (2006) Primary role of CYP1B1 in Indian juvenile-onset POAG patients. Mol Vis 12: 399-404.
41. Acharya M, Mookherjee S, Bhattacharjee A, Thakur SK, Bandyopadhyay AK, et al. (2007) Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change. BMC Mol Biol 8: 21.
42. Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, et al. (2008) Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma. Mol Vis 14: 841-50.
43. Indian Genome Variation Consortium, (2008) Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 87: 3-20.
44. Swindell SR, Plasterer TN, (1997) SEQMAN. Contig assembly. Methods Mol Biol 70: 75-89.
45. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, et al. (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35: D823-8.
46. Watterson G, (1975) On the number of segregating sites in genetical models without recombination. Theor Popul Biol. Apr 7: 256-76.
47. Welch BL, (1947) The generalisation of student's problems when several different population variances are involved. Biometrika 34: 28-35.
48. Smirnov N, (1948) Tables for estimating the goodness of fit of empirical distributions. Annals of Mathematical Statistics 19: 279.
49. Kolmogorov A, (1933) Sulla determinazione empirica di una legge di distribuzione. G. Inst. Ital. Attuari 4: 83.
50. Pereira L, Freitas F, Fernandes V, Pereira JB, Costa MD, et al. (2009) The diversity present in 5140 human mitochondrial genomes. Am J Hum Genet 84: 628-40.
51. Ingman M, Kaessmann H, Paabo S, Gyllensten U, (2000) Mitochondrial genome variation and the origin of modern humans. Nature 408: 708-13.
52. Ray K, Mookherjee S, (2009) Molecular complexity of primary open angle glaucoma: current concepts. J Genet 88: 451-67.
53. Leung D (2009) Normal Tension Glaucoma- a Sick Eye in a Sick Body. The Hong Kong Medical Diary 12.
54. Brandt U, (2006) Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 75: 69-92.
55. Boveris A, Cadenas E, (2000) Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 50: 245-50.
56. Chance B, Sies H, Boveris A, (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605.
57. Turrens JF, (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-44.
58. Boveris A, Chance B, (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-16.
59. Kao MC, Di Bernardo S, Nakamaru-Ogiso E, Miyoshi H, Matsuno-Yagi A, et al. (2005) Characterization of the membrane domain subunit NuoJ (ND6) of the NADH-quinone oxidoreductase from Escherichia coli by chromosomal DNA manipulation. Biochemistry 44: 3562-71.
60. Cardol P, Matagne RF, Remacle C, (2002) Impact of mutations affecting ND mitochondria-encoded subunits on the activity and assembly of complex I in Chlamydomonas. Implication for the structural organization of the enzyme. J Mol Biol 319: 1211-21.
61. Carelli V, Ghelli A, Bucchi L, Montagna P, De Negri A, et al. (1999) Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol 45: 320-8.
62. Brown MD, Voljavec AS, Lott MT, Torroni A, Yang CC, et al. (1992) Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 130: 163-73.
63. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, et al. (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427-30.
64. Naini AB, Lu J, Kaufmann P, Bernstein RA, Mancuso M, et al. (2005) Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol 62: 473-6.
65. Valente L, Piga D, Lamantea E, Carrara F, Uziel G, et al. (2009) Identification of novel mutations in five patients with mitochondrial encephalomyopathy. Biochim Biophys Acta 1787: 491-501.
66. Kwong JQ, Beal MF, Manfredi G, (2006) The role of mitochondria in inherited neurodegenerative diseases. J Neurochem 97: 1659-75.
67. Greenamyre JT, Sherer TB, Betarbet R, Panov AV, (2001) Complex I and Parkinson's disease. IUBMB Life 52: 135-41.
68. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr, (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26: 5256-64.
69. Arenas J, Campos Y, Ribacoba R, Martin MA, Rubio JC, et al. (1998) Complex I defect in muscle from patients with Huntington's disease. Ann Neurol 43: 397-400.
70. Schapira AH, (2002) Primary and secondary defects of the mitochondrial respiratory chain. J Inherit Metab Dis 25: 207-14.
71. Navarro A, Boveris A (2010) Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease. Front Aging Neurosci 2.
72. DiMauro S, Hirano M, (2005) Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 15: 276-86.
73. Nakamaru-Ogiso E, Kao MC, Chen H, Sinha SC, Yagi T, et al. (2010) The membrane subunit NuoL(ND5) is involved in the indirect proton pumping mechanism of Escherichia coli complex I. J Biol Chem. 285: 39070-8.
74. Blok MJ, Spruijt L, de Coo IF, Schoonderwoerd K, Hendrickx A, et al. (2007) Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. J Med Genet 44: e74.
75. Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, et al. (2000) A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol 48: 730-6.
76. Han CB, Ma JM, Xin Y, Mao XY, Zhao YJ, et al. (2005) Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance. World J Gastroenterol 11: 31-5.
77. Guan MX, (2011) Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion 11: 237-45.
78. Lu J, Li Z, Zhu Y, Yang A, Li R, et al. (2010) Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Mitochondrion 10: 380-90.
79. Zhao H, Young WY, Yan Q, Li R, Cao J, et al. (2005) Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss. Nucleic Acids Res 33: 1132-9.
80. Davies J, Davis BD, (1968) Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. The effect of drug concentration. J Biol Chem 243: 3312-6.
81. Noller HF, (1991) Ribosomal RNA and translation. Annu Rev Biochem 60: 191-227.
82. Bhattacharya SK, Rockwood EJ, Smith SD, Bonilha VL, Crabb JS, et al. (2005) Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 280: 6080-4.
83. Salinas T, Duchene AM, Marechal-Drouard L, (2008) Recent advances in tRNA mitochondrial import. Trends Biochem Sci 33: 320-9.
84. Tarassov I, Kamenski P, Kolesnikova O, Karicheva O, Martin RP, et al. (2007) Import of nuclear DNA-encoded RNAs into mitochondria and mitochondrial translation. Cell Cycle 6: 2473-7.
85. McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM, (2004) Assigning pathogenicity to mitochondrial tRNA mutations: when "definitely maybe" is not good enough. Trends Genet 20: 591-6.
86. Elson JL, Swalwell H, Blakely EL, McFarland R, Taylor RW, et al. (2009) Pathogenic mitochondrial tRNA mutations-which mutations are inherited and why? Hum Mutat 30: E984-92.
87. Scaglia F, Wong LJ, (2008) Human mitochondrial transfer RNAs: role of pathogenic mutation in disease. Muscle Nerve 37: 150-71.
88. Zifa E, Giannouli S, Theotokis P, Stamatis C, Mamuris Z, et al. (2007) Mitochondrial tRNA mutations: clinical and functional perturbations. RNA Biol 4: 38-66.
89. Florentz C, (2002) Molecular investigations on tRNAs involved in human mitochondrial disorders. Biosci Rep 22: 81-98.
90. Herrnstadt C, Howell N, (2004) An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders. Mitochondrion 4: 791-8.
91. Andrews R, Ressiniotis T, Turnbull DM, Birch M, Keers S, et al. (2006) The role of mitochondrial haplogroups in primary open angle glaucoma. Br J Ophthalmol 90: 488-90.
92. Abu-Amero KK, Morales J, Bosley TM, Mohamed GH, Cabrera VM, (2008) The role of mitochondrial haplogroups in glaucoma: a study in an Arab population. Mol Vis 14: 518-22.
93. Abu-Amero KK, Gonzalez AM, Osman EA, Larruga JM, Cabrera VM, et al. (2011) Mitochondrial DNA lineages of African origin confer susceptibility to primary open-angle glaucoma in Saudi patients. Mol Vis 17: 1468-72.
94. Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA, (2003) Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol 48: 295-313.
95. Babizhayev MA, Brodskaya MW, (1993) Immunohistochemical monitoring of the effect of a synthetic fibronectin-like peptide (Arg-Gly-Asp) on the age-related changes in the isolated human corneoscleral tissue of glaucomatous eyes. Mechanisms of Ageing & Development 72: 1-12.
96. Goto H, Dickins B, Afgan E, Paul IM, Taylor J, et al. (2011) Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study. Genome Biol 12: R59.